The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability- Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2296
https://www.valueinhealthjournal.com/article/S1098-3015(16)33662-2/fulltext
Section Title : Disease-Specific Studies
Section Order : 2176
First Page : A748
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33662-2&doi=10.1016/j.jval.2016.09.2296
HEOR Topics :
Tags :
Regions :